Retrospective Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Dec 26, 2021; 9(36): 11208-11219
Published online Dec 26, 2021. doi: 10.12998/wjcc.v9.i36.11208
Table 4 Patient characteristics and the composite outcome of in-hospital adverse events: Results of univariate analysis

With AEs (n = 86)
Without AEs (n = 142)
P value
Female, n (%)30 (34.9)39 (27.5)0.279
NYHA Class III/IV, n (%)79 (91.9)115 (80.9)0.010
Frailty, n (%)62 (72.1)73 (51.4)0.002
Hypertension, n (%)54 (62.8)72 (50.7)0.075
DM, n (%)33 (38.4)53 (37.3)0.874
Dyslipidemia, n (%)18 (20.9)33 (23.2)0.685
AF, n (%)28 (32.6)30 (21.1)0.055
Age (yr)72.05 ± 7.4668.65 ± 5.90< 0.001
Handgrip strength (kg)22.26 ± 5.3423.04 ± 4.440.030
Overall SPPB score7.50 ± 2.048.18 ± 1.610.006
SBP (mmHg)110.87 ± 23.24109.92 ± 21.620.759
DBP (mmHg)69.34±15.1368.78 ± 11.920.772
PaO2 (mmHg)99.23 ± 47.5698.20 ± 25.870.853
LVEF (%)33.74 ± 6.4533.97 ± 5.530.786